Partial
Partially Aligned
Patient Risk:
Low
Summary
The prompt includes only the boxed warning/pediatric-use material from the label; several drug-label elements are not evaluated and other claims about mechanism/class are not supported by the provided label excerpts, resulting in partial alignment.
Category Scores
Accurate Statements
TRINTELLIX is not approved for pediatric use and the boxed warning describes increased risk of suicidal thoughts and behavior in pediatric and young adult patients.
Boxed Warning (Suicidal Thoughts and Behaviors in Pediatric and Young Adult Patients) and 8.4 Pediatric Use (and corroborated by 5.1).
Unsupported Statements
Trintellix belongs to the class of drugs known as serotonin modulators and stimulators.
No supporting information for drug class/mechanism is present in the provided label excerpts.
Trintellix is not a classic SSRI.
No supporting information for whether it is or is not a classic SSRI is present in the provided label excerpts.
Trintellix works by affecting several serotonin receptors and the serotonin system.
No mechanism-of-action details are present in the provided label excerpts.
Contradictions
Important Omissions
The response does not directly and completely address the indication claim from the label excerpt (TRINTELLIX is indicated for MDD in adults) within the evaluation content shown.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The only clearly supported label-based safety content in the provided excerpts is the boxed warning/pediatric risk, which was aligned; however, unsupported mechanism/class statements were included.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Several non-boxed-warning claims (drug class and mechanism) are unsupported by the provided label excerpts, and the adult MDD indication is not explicitly evaluated in the submitted label-alignment discussion content.
Suggested Improvement
Restrict claims to what is supported by the provided label excerpts (boxed warning, pediatric use, and any explicitly quoted indication text), and avoid mechanism/class assertions unless the corresponding label sections are supplied.